NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer, Pierre Legault will present a corporate overview of the Company and meet with investors at the Bio-Europe® 2014 healthcare conference in Frankfurt, Germany.
Help employers find you! Check out all the jobs and post your resume.
